The first human TrkA-derived oncogene, Trk-oncogene, was identified in colon cancer as a novel chimeric fusion between truncated tropomyosin and protein tyrosine kinase sequence [3]. The gene discussed is NTRK1; the disease is malignant colon neoplasm.